Clinical Trial Update: Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of doxorubicin and docetaxel in women with stage III breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• Taxotere (docetaxel)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED